Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1991;18:278-288

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bunkenburg, B.
Right arrow Articles by Wood, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bunkenburg, B.
Right arrow Articles by Wood, J. M.

Hypertension, Vol 18, 278-288, Copyright © 1991 by American Heart Association


ARTICLES

Prolonged angiotensin II antagonism in spontaneously hypertensive rats. Hemodynamic and biochemical consequences

B Bunkenburg, C Schnell, HP Baum, F Cumin and JM Wood
Department of Cardiovascular Research, CIBA-GEIGY Limited, Basel, Switzerland.

The present study examines the effects of prolonged angiotensin II antagonism in spontaneously hypertensive rats by using an angiotensin II receptor antagonist (DuP 753) that is devoid of agonistic properties and selective for the subtype 1 of the angiotensin II (AT1) receptor. The antihypertensive effects of DuP 753 and its effects on circulating parameters of the renin-angiotensin system were compared with those of a converting enzyme inhibitor (benazeprilat). To minimize any influence of differences in the pharmacokinetic properties of the two blockers, administration was by continuous intravenous infusion. The experiments were performed in conscious, freely moving rats with continuous 24-hour monitoring of blood pressure. DuP 753 (10 or 30 mg/kg/day) lowered mean arterial pressure to the same extent as benazeprilat (3 or 10 mg/kg/day) during a 48-hour period. The antihypertensive effect was sustained when the treatment was extended to 7 days (DuP 753, 10 mg/kg/day; benazeprilat, 3 mg/kg/day). Neither of the compounds affected the baseline or diurnal rhythm of heart rate. Plasma concentrations of renin and angiotensin II were increased sevenfold and 10-fold, respectively, in the rats treated with DuP 753. In rats treated with benazeprilat, plasma renin concentration increased threefold, whereas angiotensin II was unchanged. Heart weights were significantly reduced to a similar extent by DuP 753 and benazeprilat. Both compounds also induced a smaller but significant decrease in blood pressure in Wistar-Kyoto rats. Our results indicate that the antihypertensive effects of converting enzyme inhibitors in spontaneously hypertensive rats are mainly due to the blockade of the renin-angiotensin system. In this rat model, angiotensin II appears to play an important role in the maintenance of hypertension that is mediated via the AT1 receptor.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Nieves-Cintron, G. C. Amberg, M. F. Navedo, J. D. Molkentin, and L. F. Santana
The control of Ca2+ influx and NFATc3 signaling in arterial smooth muscle during hypertension
PNAS, October 7, 2008; 105(40): 15623 - 15628.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. M. Gardiner, J. E. March, P. A. Kemp, S. A. Ballard, and T. Bennett
Regional Hemodynamic Effects of Neutral Endopeptidase Inhibition and Angiotensin (AT1) Receptor Antagonism Alone or in Combination in Conscious Spontaneously Hypertensive Rats
J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 340 - 348.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Feletou and P. M. Vanhoutte
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H985 - H1002.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. H. Dubinion, Z. Mi, and E. K. Jackson
Role of Renal Sympathetic Nerves in Regulating Renovascular Responses to Angiotensin II in Spontaneously Hypertensive Rats
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1330 - 1336.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Zhou, J. Pavel, M. Macova, Z.-X. Yu, H. Imboden, L. Ge, T. Nishioku, J. Dou, E. Delgiacco, and J. M. Saavedra
AT1 Receptor Blockade Regulates the Local Angiotensin II System in Cerebral Microvessels From Spontaneously Hypertensive Rats
Stroke, May 1, 2006; 37(5): 1271 - 1276.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. H. Dubinion, Z. Mi, C. Zhu, L. Gao, and E. K. Jackson
Pancreatic Polypeptide-Fold Peptide Receptors and Angiotensin II-Induced Renal Vasoconstriction
Hypertension, March 1, 2006; 47(3): 545 - 551.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. J. Bolterman, M. C. Manriquez, M. C. O. Ruiz, L. A. Juncos, and J. C. Romero
Effects of Captopril on the Renin Angiotensin System, Oxidative Stress, and Endothelin in Normal and Hypertensive Rats
Hypertension, October 1, 2005; 46(4): 943 - 947.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Gao, C. Zhu, and E. K. Jackson
alpha 2-Adrenoceptors Potentiate Angiotensin II- and Vasopressin-Induced Renal Vasoconstriction in Spontaneously Hypertensive Rats
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 581 - 586.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. F. Reckelhoff and J. C. Romero
Role of oxidative stress in angiotensin-induced hypertension
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R893 - R912.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. K. Jackson, W. A. Herzer, C. K. Kost Jr, and S. J. Vyas
Enhanced Interaction Between Renovascular {alpha}2-Adrenoceptors and Angiotensin II Receptors in Genetic Hypertension
Hypertension, September 1, 2001; 38(3): 353 - 360.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
W. Wienen and H.-J. Schierok
Effects of telmisartan, hydrochlorothiazide and their combination on blood pressure and renal excretory parameters in spontaneously hypertensive rats
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2001; 2(2): 123 - 128.
[Abstract] [PDF]


Home page
HypertensionHome page
H. M. Siragy, M. de Gasparo, and R. M. Carey
Angiotensin Type 2 Receptor Mediates Valsartan-Induced Hypotension in Conscious Rats
Hypertension, May 1, 2000; 35(5): 1074 - 1077.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. K. Jackson, W. A. Herzer, Z. Mi, S. J. Vyas, and C. K. Kost Jr
Low-Dose Angiotensin II Reduces Urinary Cyclic AMP Excretion in Spontaneously Hypertensive, But Not Normotensive, Rats: Independence from Hypertension and Renal Hemodynamic Effects of Angiotensin
J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 115 - 123.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
E. K. Jackson, W. A. Herzer, S. J. Vyas, and C. K. Kost Jr
Angiotensin II-Induced Renal Vasoconstriction in Genetic Hypertension
J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 329 - 334.
[Abstract] [Full Text]


Home page
HypertensionHome page
D. P. Healy and L. Song
Kidney Aminopeptidase A and Hypertension, Part I : Spontaneously Hypertensive Rats
Hypertension, February 1, 1999; 33(2): 740 - 745.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. P. Collister and J. W. Osborn
Area postrema lesion attenuates the long-term hypotensive effects of losartan in salt-replete rats
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1998; 274(2): R357 - R366.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Benetos, B. I. Levy, P. Lacolley, F. Taillard, M. Duriez, and M. E. Safar
Role of Angiotensin II and Bradykinin on Aortic Collagen Following Converting Enzyme Inhibition in Spontaneously Hypertensive Rats
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3196 - 3201.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. Lantelme, M. Lo, L. Luttenauer, and J. Sassard
Pivotal role of the renin-angiotensin system in Lyon hypertensive rats
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1997; 273(5): R1793 - R1799.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Tamura, S. Umemura, N. Nyui, T. Yamakawa, S. Yamaguchi, T. Ishigami, S.-i. Tanaka, K. Tanimoto, N. Takagi, H. Sekihara, et al.
Tissue-Specific Regulation of Angiotensinogen Gene Expression in Spontaneously Hypertensive Rats
Hypertension, June 1, 1996; 27(6): 1216 - 1223.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. Notoya, M. Nakamura, and K. Mizojiri
Effects of Lisinopril on the Structure of Renal Arterioles
Hypertension, March 1, 1996; 27(3): 364 - 370.
[Abstract] [Full Text]


Home page
HypertensionHome page
J. P. Collister, B. J. Hornfeldt, and J. W. Osborn
Hypotensive Response to Losartan in Normal Rats : Role of Ang II and the Area Postrema
Hypertension, March 1, 1996; 27(3): 598 - 606.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
J. H. Bauer and G. P. Reams
The Angiotensin II Type 1 Receptor Antagonists: A New Class of Antihypertensive Drugs
Arch Intern Med, July 10, 1995; 155(13): 1361 - 1368.
[Abstract] [PDF]


Home page
HypertensionHome page
M. Ikeda, M. Kohno, and T. Takeda
Endothelin Production in Cultured Mesangial Cells of Spontaneously Hypertensive Rats
Hypertension, June 1, 1995; 25(6): 1196 - 1201.
[Abstract] [Full Text]


Home page
HypertensionHome page
M. Ikeda, M. Kohno, and T. Takeda
Endothelin Production in Cultured Mesangial Cells of Spontaneously Hypertensive Rats
Hypertension, April 1, 1995; 25(4): 1 - 6.
[Abstract] [Full Text]